Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.

Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.

• Phase: Phase 1

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Bevacizumab; Diclofenac

Criteria

Inclusion Criteria:

• patients with clinically significant macular edema and diffuse macular edema

Exclusion Criteria:

• any history of focal photocoagulation

• any prior intra ocular injection

• history of glaucoma with high pressure

• history of ophthalmic surgery

• high rish PDR

• active PDR